Erasca, Inc. (ERAS)
18.00
-0.03
(-0.17%)
USD |
NASDAQ |
Aug 31, 09:33
Erasca Cash and Short Term Investments (Quarterly) : 268.74M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 268.74M |
| March 31, 2026 | 243.79M |
| December 31, 2025 | 276.08M |
| September 30, 2025 | 288.40M |
| June 30, 2025 | 300.66M |
| March 31, 2025 | 304.58M |
| December 31, 2024 | 298.31M |
| September 30, 2024 | 318.91M |
| June 30, 2024 | 408.41M |
| March 31, 2024 | 297.68M |
| December 31, 2023 | 312.35M |
| September 30, 2023 | 296.67M |
| Date | Value |
|---|---|
| June 30, 2023 | 317.24M |
| March 31, 2023 | 389.74M |
| December 31, 2022 | 435.62M |
| September 30, 2022 | 355.93M |
| June 30, 2022 | 371.48M |
| March 31, 2022 | 392.53M |
| December 31, 2021 | 414.48M |
| September 30, 2021 | 486.64M |
| June 30, 2021 | 193.67M |
| March 31, 2021 | 212.34M |
| December 31, 2020 | 118.70M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 3.938B |
| Tango Therapeutics, Inc. | 1.014B |
| Cogent Biosciences, Inc. | 792.30M |
| Apogee Therapeutics, Inc. | 971.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |